HNF1A rs7910555: hsCRP Levels and Metabolic Traits

What each genotype means

Genomic Location and Variant Characteristics

The variant rs7910555 is a single nucleotide polymorphism positioned on chromosome 12 inside the genomic span of the HNF1A locus. Unlike rare coding mutations that severely disrupt peptide structure, rs7910555 is a standard sequence alteration with an exchange between cytosine and thymine alleles. Polymorphisms across this region typically influence regulatory mechanisms, such as transcription factor binding efficiency, splicing, or quantitative expression, rather than completely halting protein production. Large-scale catalogs such as dbSNP classify it as a common trait-associated single nucleotide polymorphism. Because it resides in an extensively mapped regulatory corridor, geneticists frequently monitor it in cohort analyses to evaluate how baseline differences in genomic sequence alter subtle downstream biomarkers in healthy human populations.

Biological Role of the HNF1A Gene

The HNF1A gene encodes hepatocyte nuclear factor-1 alpha, a major transcription factor essential for tissue-specific gene regulation across hepatocytes and pancreatic beta cells. According to [MedlinePlus Genetics: HNF1A](https://medlineplus.gov/genetics/gene/hnf1a/), this protein regulates cascades vital for glucose sensing, hepatic synthesis of transport proteins, and inflammatory pathways. Crucially, the hepatic promoter for C-reactive protein contains direct binding elements for hepatocyte nuclear factor-1 alpha. Disruption or subtle modulation of HNF-1α activity modifies the transcription rate of baseline inflammatory markers produced by the liver. While rare, penetrant loss-of-function mutations in HNF1A cause monogenic forms of diabetes such as maturity-onset diabetes of the young, common variants like rs7910555 merely tune baseline physiologic expression.

Research Evidence on hsCRP and Glycemic Variation

Multiple studies cataloged in the [GWAS Catalog](https://www.ebi.ac.uk/gwas/genes/HNF1A) and indexed in [PubMed](https://pubmed.ncbi.nlm.nih.gov/?term=HNF1A+CRP+GWAS) demonstrate that the HNF1A locus strongly governs circulating high-sensitivity C-reactive protein levels. Cohorts such as the Women's Health Study and trans-ancestry cohorts have consistently mapped CRP variation to HNF1A. Research also explores ties between this locus and subtle changes in glycemic parameters and lipid balance. However, the evidence specifically highlighting rs7910555 as an independent causal driver remains limited; it is largely categorized as an associated proxy marker reflecting background polygenic architecture. Furthermore, statistical correlations with circulating hsCRP do not necessarily translate into direct changes in cardiovascular disease risk, as Mendelian randomization studies show that genetically altered baseline CRP levels do not uniformly alter atherogenic vascular outcomes.

Population Distribution and Ancestry Patterns

Data from large population resources such as [gnomAD](https://gnomad.broadinstitute.org/) indicate that rs7910555 is a common variant across several global cohorts. In European populations, the minor allele maintains a frequency of approximately 0.30, meaning roughly half of all individuals carry at least one copy of the variant allele. Frequencies vary among non-European groups, such as African, East Asian, and Admixed American ancestries, where distinct linkage disequilibrium structures shift allele representation. Because allele frequencies fluctuate geographically, the specific baseline predictive power of this marker is population-dependent. Consequently, research findings observed in predominantly European datasets cannot be uncritically generalized to every demographic without localized genomic validation.

Clinical Utility and Lifestyle Considerations

Having a specific genotype at rs7910555 does not diagnose an illness or predict clinical heart disease, diabetes, or autoimmune disorders. Clinical high-sensitivity C-reactive protein testing is primarily applied as a broad systemic indicator of inflammation, which fluctuates significantly with infection, body composition, sleep patterns, and physical activity. Genetic variation in HNF1A simply explains a fraction of the baseline, non-pathological variance seen between different people. A reader cannot modify their inherited genomic sequence, nor should they attempt to self-medicate based on this result. Any medical questions regarding blood inflammation markers, glycemic control, or overall cardiometabolic wellness should always be interpreted by a healthcare professional within the context of comprehensive laboratory panels and overall lifestyle health.

Frequently asked questions

Sources & further reading